Alessandro Isidori Selected Research

Alessandro Isidori Research Topics

Disease

15	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 05/2002
11	Primary Myelofibrosis (Myelosclerosis) 01/2021 - 02/2018
11	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021 - 12/2010
10	Neoplasms (Cancer) 01/2021 - 07/2004
9	Lymphoma (Lymphomas) 01/2021 - 09/2003
7	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 09/2003
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2018 - 04/2005
5	Leukemia 01/2021 - 09/2003
5	Hodgkin Disease (Hodgkin's Disease) 01/2019 - 09/2011
3	Thrombocytopenia (Thrombopenia) 10/2018 - 09/2004
2	Residual Neoplasm 01/2021 - 08/2014
2	Blast Crisis (Blast Phase) 08/2020 - 01/2020
2	Splenomegaly 10/2018 - 04/2018
2	Infections 04/2018 - 09/2004
2	Anemia 02/2018 - 10/2014
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2007 - 12/2006
2	Pain (Aches) 03/2007 - 02/2005
2	Neutropenia 02/2005 - 09/2004
1	Thrombosis (Thrombus) 01/2021
1	Thrombocytosis (Thrombocythemia) 01/2021
1	COVID-19 01/2021
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2021
1	Skin Neoplasms (Skin Cancer) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Disease Progression 10/2020
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019
1	Essential Thrombocythemia 10/2018
1	Polycythemia Vera 10/2018
1	Exanthema (Rash) 10/2014
1	Muscle Cramp (Cramp) 10/2014
1	Pericardial Effusion 04/2011
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2011
1	Cardiotoxicity 03/2009
1	Pulmonary Embolism 06/2008
1	Heart Failure 06/2008
1	beta-Thalassemia (Cooley's Anemia) 12/2007
1	Pure Red-Cell Aplasia 12/2007

Drug/Important Bio-Agent (IBA)

11	ruxolitinibIBA 01/2021 - 02/2018
6	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2020 - 07/2004
6	Imatinib Mesylate (Gleevec)FDA Link 10/2017 - 12/2010
5	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2014
5	Pharmaceutical PreparationsIBA 01/2020 - 03/2009
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2007
3	Etoposide (VP 16)FDA LinkGeneric 11/2014 - 02/2005
3	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2011 - 06/2008
3	liposomal doxorubicin (Doxil)FDA Link 01/2011 - 06/2008
2	nilotinib FDA Link 01/2021 - 10/2017
2	AnthracyclinesIBA 01/2019 - 03/2009
2	ponatinibIBA 09/2018 - 01/2016
2	Bendamustine Hydrochloride FDA Link 11/2014 - 09/2011
2	Melphalan (Alkeran)FDA LinkGeneric 11/2014 - 09/2011
2	fludarabineIBA 09/2011 - 04/2005
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2011 - 01/2011
2	Dasatinib (BMS 354825)FDA Link 04/2011 - 12/2010
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	isocitric acid (isocitrate)IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Biological ProductsIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	VaccinesIBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	IronIBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	tosedostatIBA 10/2020
1	venetoclaxIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	CalreticulinIBA 01/2019
1	SteroidsIBA 01/2019
1	Therapeutic UsesIBA 04/2018
1	Lenalidomide (CC 5013)FDA Link 11/2017
1	Complement System Proteins (Complement)IBA 01/2017
1	Carmustine (FIVB)FDA Link 08/2015
1	HomoharringtonineIBA 01/2014
1	Indicators and Reagents (Reagents)IBA 01/2013
1	Interleukin-2 (IL2)IBA 09/2011
1	LigandsIBA 09/2011
1	KIR ReceptorsIBA 09/2011
1	Vincristine (Oncovin)FDA LinkGeneric 01/2011
1	Rituximab (Mabthera)FDA Link 01/2011
1	Prednisolone (Predate)FDA LinkGeneric 01/2011
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 04/2007
1	Immunosuppressive Agents (Immunosuppressants)IBA 04/2007
1	Alemtuzumab (Campath)FDA Link 12/2006
1	Ganciclovir (Cytovene)FDA LinkGeneric 12/2006

Therapy/Procedure

15	Therapeutics 01/2021 - 07/2004
9	Drug Therapy (Chemotherapy) 01/2020 - 09/2003
9	Stem Cell Transplantation 01/2019 - 01/2005
5	Transplantation 08/2015 - 09/2003
3	Immunotherapy 01/2021 - 07/2004
1	Homologous Transplantation 01/2020
1	Salvage Therapy 01/2020
1	Radioimmunotherapy 03/2018
1	Polypharmacy 11/2016
1	Radiotherapy 08/2015
1	Drug Tapering 10/2014
1	Consolidation Chemotherapy 08/2014